Inovio Pharmaceuticals, Inc.INONASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, above historical average, modest growth trend.
Left:
||||
Year-over-year operating income growth rate
Latest
21.91%
↑ 198% above average
Average (9y)
-22.46%
Historical baseline
Range
High:46.21%
Low:-142.76%
CAGR
+5.8%
Consistent expansion
| Period | Value |
|---|---|
| 2024 | 21.91% |
| 2023 | 46.21% |
| 2022 | 11.17% |
| 2021 | -142.76% |
| 2020 | -11.68% |
| 2019 | -18.09% |
| 2018 | -12.49% |
| 2017 | -9.72% |
| 2016 | -122.37% |
| 2015 | 13.20% |